Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bates

Showing results (1111-1120 of 1,204) with videos related to

Pageof 121
Sort By:
The Oncologist|November 11, 2022
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World DataCeline Yeh, Mengxi Zhou, Keith Sigel, et al.
The Lancet. Oncology|June 27, 2024
Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendationsAnnette M Lim, Christophe Le Tourneau, Chris Hurt, et al.
British Journal of Haematology|October 31, 2009
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphomaSusan E Bates, Zhirong Zhan, Kenneth Steadman, et al.
Frontiers in Immunology|February 19, 2024
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responsesJames Tristan Gordy, Yinan Hui, Courtney Schill, et al.
Cancer|October 21, 2018
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs dataJoshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
The Lancet. Oncology|December 17, 2016
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysisJulia Wilkerson, Kald Abdallah, Charles Hugh-Jones, et al.
Developmental Psychology|March 29, 2003
Developmental trajectories of childhood disruptive behaviors and adolescent delinquency: a six-site, cross-national studyLisa M Broidy, Daniel S Nagin, Richard E Tremblay, et al.
Psychological Science|March 29, 2011
CHRM2, parental monitoring, and adolescent externalizing behavior: evidence for gene-environment interactionDanielle M Dick, Jacquelyn L Meyers, Shawn J Latendresse, et al.
Developmental Cell|October 24, 2023
In vitro generation of mouse morula-like cellsHuanhuan Li, Litao Chang, Jinyi Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasmsVictor Sandor, Susan Bakke, Robert W Robey, et al.
Pageof 121

Showing results (1111-1120 of 1,204) with videos related to

Sort By:
Pageof 121
The Oncologist|November 11, 2022
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World DataCeline Yeh, Mengxi Zhou, Keith Sigel, et al.
The Lancet. Oncology|June 27, 2024
Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendationsAnnette M Lim, Christophe Le Tourneau, Chris Hurt, et al.
British Journal of Haematology|October 31, 2009
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphomaSusan E Bates, Zhirong Zhan, Kenneth Steadman, et al.
Frontiers in Immunology|February 19, 2024
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responsesJames Tristan Gordy, Yinan Hui, Courtney Schill, et al.
Cancer|October 21, 2018
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs dataJoshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
The Lancet. Oncology|December 17, 2016
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysisJulia Wilkerson, Kald Abdallah, Charles Hugh-Jones, et al.
Developmental Psychology|March 29, 2003
Developmental trajectories of childhood disruptive behaviors and adolescent delinquency: a six-site, cross-national studyLisa M Broidy, Daniel S Nagin, Richard E Tremblay, et al.
Psychological Science|March 29, 2011
CHRM2, parental monitoring, and adolescent externalizing behavior: evidence for gene-environment interactionDanielle M Dick, Jacquelyn L Meyers, Shawn J Latendresse, et al.
Developmental Cell|October 24, 2023
In vitro generation of mouse morula-like cellsHuanhuan Li, Litao Chang, Jinyi Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasmsVictor Sandor, Susan Bakke, Robert W Robey, et al.
Pageof 121